SCHEMBL24959192

SCHEMBL24959192

COc1nnc(COc2cccc(Br)n2)s1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.44
POLB P06746 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 3/20 0.35
FFAR1 O14842 2/20 0.34
RAB9A P51151 3/20 0.33
PTPRE P23469 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
PKM P14618 1/20 0.33
CDK9 P50750 1/20 0.32
DYRK1A Q13627 1/20 0.32
DYRK2 Q92630 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ABL1 P00519 1/20 0.32
RIN1 Q13671 1/20 0.32
TP53 P04637 1/20 0.31
TSHR P16473 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30027652 1.00 HTR7 (0.44) HTR7POLBALDH1A1MAPTFFAR1
SCHEMBL24958756 0.88 HTR7 (0.43) HTR7POLBALDH1A1MAPTRAB9A
SCHEMBL31438106 0.88 HTR7 (0.43) HTR7POLBALDH1A1MAPTRAB9A
SCHEMBL30029312 0.83 HTR7 (0.47) HTR7POLBALDH1A1MAPTRAB9A
SCHEMBL24958809 0.83 HTR7 (0.47) HTR7POLBALDH1A1MAPTRAB9A
SCHEMBL24956394 0.82 HTR7 (0.38) HTR7FFAR1PKM
SCHEMBL31438105 0.82 HTR7 (0.38) HTR7FFAR1PKM
SCHEMBL29160032 0.82 HTR7 (0.38) HTR7PKM
SCHEMBL24959011 0.81 HTR7 (0.39) HTR7MAPT
SCHEMBL30027761 0.81 HTR7 (0.39) HTR7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295729-A Carboxy-benzimidazole GLP-1R modulating compounds 吉利德科学公司 2023-12-26 CN disclosed
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 HTR7 280/4885POLB 4668/4885ALDH1A1 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.